The next frontier in ADME science: Predicting transporter-based drug disposition, tissue concentrations and drug-drug interactions in humans

F Storelli, M Yin, AR Kumar, MK Ladumor… - Pharmacology & …, 2022 - Elsevier
Predicting transporter-based drug clearance (CL) and tissue concentrations (TC) in humans
is important to reduce the risk of failure during drug development. In addition, when …

Drug concentration asymmetry in tissues and plasma for small molecule–related therapeutic modalities

D Zhang, CECA Hop, G Patilea-Vrana, G Gampa… - Drug Metabolism and …, 2019 - ASPET
The well accepted “free drug hypothesis” for small-molecule drugs assumes that only the
free (unbound) drug concentration at the therapeutic target can elicit a pharmacologic effect …

Toward a consensus on applying quantitative liquid chromatography‐tandem mass spectrometry proteomics in translational pharmacology research: a white paper

B Prasad, B Achour, P Artursson… - Clinical …, 2019 - Wiley Online Library
Quantitative translation of information on drug absorption, disposition, receptor engagement,
and drug–drug interactions from bench to bedside requires models informed by …

In vitro and in vivo methods to assess pharmacokinetic drug– drug interactions in drug discovery and development

C Lu, L Di - Biopharmaceutics & drug disposition, 2020 - Wiley Online Library
Drug–drug interactions (DDIs) caused by the co‐administration of multiple drugs are major
safety concerns in the clinic. Several drugs have been withdrawn from the market due to …

Successful and unsuccessful prediction of human hepatic clearance for lead optimization

JK Sodhi, LZ Benet - Journal of medicinal chemistry, 2021 - ACS Publications
Development of new chemical entities is costly, time-consuming, and has a low success
rate. Accurate prediction of pharmacokinetic properties is critical to progress compounds …

Plasma protein-mediated uptake and contradictions to the free drug hypothesis: a critical review

JA Schulz, DM Stresser, JC Kalvass - Drug metabolism reviews, 2023 - Taylor & Francis
According to the free drug hypothesis (FDH), only free, unbound drug is available to interact
with biological targets. This hypothesis is the fundamental principle that continues to explain …

Application of empirical scalars to enable early prediction of human hepatic clearance using in vitro-in vivo extrapolation in drug discovery: an evaluation of 173 drugs

RS Jones, C Leung, JH Chang, S Brown, N Liu… - Drug Metabolism and …, 2022 - ASPET
The utilization of in vitro data to predict drug pharmacokinetics (PK) in vivo has been a
consistent practice in early drug discovery for decades. However, its success is hampered …

Primary human hepatocyte spheroids as an in vitro tool for investigating drug compounds with low hepatic clearance

J Riede, BM Wollmann, E Molden… - Drug Metabolism and …, 2021 - ASPET
Characterizing the pharmacokinetic properties of drug candidates represents an essential
task during drug development. In the past, liver microsomes and primary suspended …

Impact of plasma protein binding in drug clearance prediction: a database analysis of published studies and implications for in vitro-in vivo extrapolation

LJ Francis, JB Houston, D Hallifax - Drug Metabolism and Disposition, 2021 - ASPET
Plasma protein–mediated uptake (PMU) and its effect on clearance (CL) prediction have
been studied in various formats; however, a comprehensive analysis of the overall impact of …

Investigating the Theoretical Basis for In VitroIn Vivo Extrapolation (IVIVE) in Predicting Drug Metabolic Clearance and Proposing Future Experimental Pathways

LZ Benet, JK Sodhi - The AAPS journal, 2020 - Springer
Extensive studies have been conducted to predict in vivo metabolic clearance from in vitro
human liver metabolism parameters (ie, in vitro–in vivo extrapolation (IVIVE)) with little …